Bio Path reported $4.9M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Baxter International USD 999M 46M Dec/2025
Bio Path USD 4.9M 1.42M Sep/2025
Cipla INR 30.35B 1.98B Sep/2025
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.35M 6.77M Dec/2025
CSL USD 3.17B 290M Dec/2025
Grifols EUR 987.75M 47.87M Dec/2025
Karyopharm Therapeutics USD 4M 1.39M Dec/2025